Published September 2014 | Version v1
Journal article Metadata-only

Safety and adverse events of neoadjuvant short-course hyperfractionated accelerated radiotherapy (SC-HART) for rectal cancer

Creators

  • 1. Hyogo College of Medicine, School of Medicine, Nishinomiya, Hyogo (Japan)
  • 2. Meiwa Hospital, Nishinomiya, Hyogo (Japan)

Description

We presented good tolerability and short-term outcomes of neoadjuvant short-course hyperfractionated accelerated radiotherapy (SC-HART; 25 Gy in 10 fractions for 5 days) combined with chemotherapy in a total of 73 patients with lower rectal cancer. Age, gender, tumor differentiation, and the type of surgery seemed to have no apparent effects on toxicity of SC-HART. SC-HART appeared to have a good feasibility for use in further clinical trials. (author)

Additional details

Publishing Information

Journal Title
Rinsho Hoshasen
Journal Volume
59
Journal Issue
9
Journal Page Range
p. 1196-1202
ISSN
0009-9252

INIS

Country of Publication
Japan
Country of Input or Organization
Japan
INIS RN
46090033
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
ANTINEOPLASTIC DRUGS; CARCINOMAS; CHEMOTHERAPY; COMBINED THERAPY; DELAYED RADIATION EFFECTS; EARLY RADIATION EFFECTS; EFFICIENCY; EXTERNAL BEAM RADIATION THERAPY; FRACTIONATED IRRADIATION; IRRADIATION PROCEDURES; PATIENTS; PLANNING; RADIATION INJURIES; RECTUM; SURGERY
Descriptors DEC
BIOLOGICAL EFFECTS; BIOLOGICAL RADIATION EFFECTS; BODY; DIGESTIVE SYSTEM; DISEASES; DRUGS; GASTROINTESTINAL TRACT; INJURIES; INTESTINES; IRRADIATION; LARGE INTESTINE; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; ORGANS; RADIATION EFFECTS; RADIOLOGY; RADIOTHERAPY; THERAPY